Document is current
Any future updates will be listed below
-
Authors
Shafieesabet, Azadeh
Jauert, Nadja
Hartmann, Oliver
Arlt, Birte
Joebges, Michael
Doehner, Wolfram
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 2 September 2022
Accepted: 27 February 2023
First Online: 24 March 2023
Competing interests
: Oliver Hartmann and Birte Arlt are employed by sphingotec GmbH, a company holding patent rights of the bio-ADM assay. Azadeh Shafieesabet, Nadja Jauert, Michael Joebges and Wolfram Doehner declare no potential conflict of interest.
